申请人:SmithKline Beecham p.l.c.
公开号:US07026336B1
公开(公告)日:2006-04-11
Compounds of formula (I) wherein X is O, CH2, S or NH, or the moiety X—R1 is hydrogen; V is CH or N; Y is NR10R11, NR10C(Z)NR10R11, NR10COOR11 or NR10SO2R11; Ar is phenyl or a 5- or 6-membered heteroaryl ring either of which may be optionally substituted; n is 0, 1, 2, 3 or 4; and R1, R2, R3, R4, R10 and R11 have the meanings given in the description; and pharmaceutically acceptable salt thereof.
化合物的公式(I),其中X为O,CH2,S或NH,或者X-R1基团为氢;V为CH或N;Y为NR10R11,NR10C(Z)NR10R11,NR10COOR11或NR10SO2R11;Ar为苯基或5或6成员的杂环,其中任何一个都可以选择性地被取代;n为0,1,2,3或4;R1,R2,R3,R4,R10和R11具有描述中给出的含义;以及其药学上可接受的盐。